COMMUNIQUÉS West-GlobeNewswire
-
Reviewed Financial Statement's announcement for the period 30 June 2017
10/08/2017 -
Ossur Hf : Insider Trading
10/08/2017 -
Trading in Novo Nordisk shares by board members, executives and associated persons on 9 August 2017
10/08/2017 -
Zealand Pharma A/S publishes prospectus
10/08/2017 -
Zealand Pharma A/S publishes a prospectus regarding listing of 4,375,000 new shares on Nasdaq Copenhagen as part of its issue of American Depositary Shares listed on the Nasdaq in the US
10/08/2017 -
RedHill Biopharma Provides 2017 Semi-Annual Business Update
10/08/2017 -
Auris Medical Provides Business Update and Reports Second Quarter 2017 Financial Results
10/08/2017 -
Présentation de Merus à la Wedbush PacGrow Healthcare Conference 2017
10/08/2017 -
Active Biotech AB - Interim report January - June 2017
10/08/2017 -
Immunicum AB (publ) Announces Enrollment of First United States Patient in the Ongoing Phase 2 MERECA Trial for Ilixadencel
10/08/2017 -
Basilea reports improved financial results in half-year 2017 driven by growing product sales; significant progress on partnering and development programs
10/08/2017 -
ConfirmMDx Study Provides Further Validation of Epigenetic Risk Profile
10/08/2017 -
Une étude sur ConfirmMDx fournit une nouvelle validation du profil de risque épigénétique
10/08/2017 -
Zealand Pharma A/S files final prospectus on a Form F-1 registration statement in connection with the initial public offering of American Depositary Shares in the United States
09/08/2017 -
GLPG1690 halts disease progression in IPF patients in FLORA Phase 2a trial
09/08/2017 -
Bavarian Nordic Announces Subscription Price and Number of Shares to be Issued to Johnson & Johnson Innovation - JJDC, Inc.
09/08/2017 -
ProMIS Neurosciences Completes First Closing of Private Placement
09/08/2017 -
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 juillet 2017
09/08/2017 -
Stabilization period begins
09/08/2017
Pages